Influenza vaccination in kids, are you kidding me?

Journal of Infection

Volumn 68, Issue SUPPL1, 2014, Pages

  Ahout, Inge ^a   Ferwerda, Gerben ^a   de Groot, Ronald ^a  

^a Department of Internal Medicine   (Netherlands)

Author keywords

Influenza; National Immunization Program; Vaccination

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; CHILD HEALTH CARE; CHILDHOOD MORTALITY; CHILL; CONSULTATION; CONTROLLED CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; GUILLAIN BARRE SYNDROME; HEADACHE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA VACCINATION; INJECTION SITE REACTION; META ANALYSIS (TOPIC); NARCOLEPSY; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; RHINORRHEA; RISK REDUCTION; SEASONAL INFLUENZA; TREATMENT INDICATION; UPPER RESPIRATORY TRACT CONGESTION; VIRUS STRAIN; VIRUS VIRULENCE; WHEEZING;

INFLUENZA; NATIONAL IMMUNIZATION PROGRAM; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; NETHERLANDS; VACCINATION;

EID: 84889684451     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.09.019     Document Type: Article

References (112)

1. Brankston G., Gitterman L., Hirji Z., Lemieux C., Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007 Apr, 7(4):257-265.
2. World Health Organization Influenza (seasonal) 2009.
3. Taubenberger J.K., Kash J.C. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010 Jun 25, 7(6):440-451.
4. Reperant L.A., Kuiken T., Osterhaus A.D. Influenza viruses: from birds to humans. Hum Vaccin Immunother 2012 Jan, 8(1):7-16.
5. Palese P. Influenza: old and new threats. Nat Med 2004 Dec, 10(12 Suppl.):S82-S87.
6. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009 Jul 10, 325(5937):197-201.
7. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009 Jun 18, 360(25):2605-2615.
8. Libster R., Bugna J., Coviello S., Hijano D.R., Dunaiewsky M., Reynoso N., et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010 Jan 7, 362(1):45-55.
9. Bishop J.F., Murnane M.P., Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009 Dec 31, 361(27):2591-2594.
10. Lister P., Reynolds F., Parslow R., Chan A., Cooper M., Plunkett A., et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009 Aug 22, 374(9690):605-607.
11. Patel M., Dennis A., Flutter C., Khan Z. Pandemic (H1N1) 2009 influenza. Br J Anaesth 2010 Feb, 104(2):128-142.
12. Olsen B., Munster V.J., Wallensten A., Waldenstrom J., Osterhaus A.D., Fouchier R.A. Global patterns of influenza a virus in wild birds. Science 2006 Apr 21, 312(5772):384-388.
13. Hay A.J., Gregory V., Douglas A.R., Lin Y.P. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001 Dec 29, 356(1416):1861-1870.
14. Dormitzer P.R., Galli G., Castellino F., Golding H., Khurana S., Del G.G., et al. Influenza vaccine immunology. Immunol Rev 2011 Jan, 239(1):167-177.
15. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992 Mar, 56(1):152-179.
16. Matsuzaki Y., Katsushima N., Nagai Y., Shoji M., Itagaki T., Sakamoto M., et al. Clinical features of influenza C virus infection in children. J Infect Dis 2006 May 1, 193(9):1229-1235.
17. Seasonal influenza vaccination resources for health professionals 2013, http://www.cdc.gov.
18. Seasonal influenza vaccines 2013, http://www.ecdc.europe.eu.
19. WHO recommendations on the composition of influenza virus vaccines 2013, http://www.who.int.
20. Carter N.J., Curran M.P. Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 2011 Aug 20, 71(12):1591-1622.
21. Wang Z., Tobler S., Roayaei J., Eick A. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. J Am Med Assoc 2009 Mar 4, 301(9):945-953.
22. Intranasal influenza vaccination: FluMist 2013, http://www.fda.gov.
23. Intranasal influenza vaccination: FluMist 2013, http://www.ema.europe.eu.
24. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008 Oct 9, 359(15):1555-1564.
25. Subbramanian R.A., Basha S., Shata M.T., Brady R.C., Bernstein D.I. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Vaccine 2010 Dec 6, 28(52):8258-8267.
26. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005 Nov, 5(11):718-725.
27. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 2006 Jul 6, 355(1):31-40.
28. Bourgeois F.T., Valim C., McAdam A.J., Mandl K.D. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics 2009 Dec, 124(6):e1072-e1080.
29. Mereckiene J., Cotter S., Weber J.T., Nicoll A., D'Ancona F., Lopalco P.L., et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill 2012, 17(4).
30. Thorburn K., Riordan A. Pulmonary bacterial coinfection in infants and children with viral respiratory infection. Expert Rev Anti Infect Ther 2012 Aug, 10(8):909-916.
31. Heikkinen T. The role of respiratory viruses in otitis media. Vaccine 2000 Dec 8, 19(Suppl. 1):S51-S55.
32. Sauerbrei A., Schmidt-Ott R., Hoyer H., Wutzler P. Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol 2009 May, 198(2):93-101.
33. Bodewes R., de M.G., van der Klis F.R., Ventresca M., Wilks S., Smith D.J., et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 2011 Mar, 18(3):469-476.
34. Munoz F.M. Influenza virus infection in infancy and early childhood. Paediatr Respir Rev 2003 Jun, 4(2):99-104.
35. Monto A.S. Occurrence of respiratory virus: time, place and person. Pediatr Infect Dis J 2004 Jan, 23(1 Suppl.):S58-S64.
36. Peltola V., Reunanen T., Ziegler T., Silvennoinen H., Heikkinen T. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005 Oct 15, 41(8):1198-1200.
37. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000 Jan 27, 342(4):225-231.
38. Heikkinen T., Silvennoinen H., Peltola V., Ziegler T., Vainionpaa R., Vuorinen T., et al. Burden of influenza in children in the community. J Infect Dis 2004 Oct 15, 190(8):1369-1373.
39. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002 Jan 15, 185(2):147-152.
40. Ferguson N.M., Cummings D.A., Fraser C., Cajka J.C., Cooley P.C., Burke D.S. Strategies for mitigating an influenza pandemic. Nature 2006 Jul 27, 442(7101):448-452.
41. Longini I.M., Nizam A., Xu S., Ungchusak K., Hanshaoworakul W., Cummings D.A., et al. Containing pandemic influenza at the source. Science 2005 Aug 12, 309(5737):1083-1087.
42. Glezen W.P. Herd protection against influenza. J Clin Virol 2006 Dec, 37(4):237-243.
43. Recommendations for prevention and control of influenza in children, 2012-2013. Pediatrics 2012 Oct, 130(4):780-792.
44. Recommendations for using TIV and LAIV 2013.
45. Poehling K.A., Fairbrother G., Zhu Y., Donauer S., Ambrose S., Edwards K.M., et al. Practice and child characteristics associated with influenza vaccine uptake in young children. Pediatrics 2010 Oct, 126(4):665-673.
46. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007. Pediatrics 2007 Apr, 119(4):846-851.
47. Fiore A.E., Epperson S., Perrotta D., Bernstein H., Neuzil K. Expanding the recommendations for annual influenza vaccination to school-age children in the United States. Pediatrics 2012 Mar, 129(Suppl. 2):S54-S62.
48. Nokleby H., Nicoll A. Risk groups and other target groups - preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010-11. Euro Surveill 2010 Mar 25, 15(12).
49. Rapola S. National immunization program in Finland. Int J Circumpolar Health 2007 Dec, 66(5):382-389.
50. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012 Jan, 12(1):36-44.
51. Bijl D. Werkzaamheid en effectiviteit van influenzavaccinatie (Efficacy and effectiveness of influenza vaccination). Gebu 2011, 45(10):109-117.
52. Jefferson T., Di P.C., Debalini M.G., Rivetti A., Demicheli V. Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review. BMJ 2009, 338:b354.
53. Houweling H., Verweij M., Ruitenberg E.J. Criteria for inclusion of vaccinations in public programmes. Vaccine 2010 Apr 9, 28(17):2924-2931.
54. Petrie J.G., Ohmit S.E., Johnson E., Cross R.T., Monto A.S. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011 May 1, 203(9):1309-1315.
55. Dawood F.S., Fiore A., Kamimoto L., Bramley A., Reingold A., Gershman K., et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr 2010 Nov, 157(5):808-814.
56. Weigl J.A., Puppe W., Schmitt H.J. The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 2002 Dec, 129(3):525-533.
57. Montes M., Vicente D., Perez-Yarza E.G., Cilla G., Perez-Trallero E. Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001-June 2004). Vaccine 2005 Jul 29, 23(34):4302-4306.
58. Ampofo K., Gesteland P.H., Bender J., Mills M., Daly J., Samore M., et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006 Dec, 118(6):2409-2417.
59. Chiu S.S., Chan K.H., Chen H., Young B.W., Lim W., Wong W.H., et al. Virologically confirmed population-based burden of hospitalization caused by respiratory syncytial virus, adenovirus, and parainfluenza viruses in children in Hong Kong. Pediatr Infect Dis J 2010 Dec, 29(12):1088-1092.
60. Silvennoinen H., Peltola V., Vainionpaa R., Ruuskanen O., Heikkinen T. Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study. Pediatr Infect Dis J 2011 Feb, 30(2):e24-e28.
61. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005 Dec 15, 353(24):2559-2567.
62. Finelli L., Fiore A., Dhara R., Brammer L., Shay D.K., Kamimoto L., et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008 Oct, 122(4):805-811.
63. Fraaij P.L., Bodewes R., Osterhaus A.D., Rimmelzwaan G.F. The ins and outs of universal childhood influenza vaccination. Future Microbiol 2011 Oct, 6(10):1171-1184.
64. Hoberman A., Greenberg D.P., Paradise J.L., Rockette H.E., Lave J.R., Kearney D.H., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. J Am Med Assoc 2003 Sep 24, 290(12):1608-1616.
65. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb, 136(2):168-175.
66. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998 May 14, 338(20):1405-1412.
67. Vesikari T., Fleming D.M., Aristegui J.F., Vertruyen A., Ashkenazi S., Rappaport R., et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006 Dec, 118(6):2298-2312.
68. Bracco N.H., Farhat C.K., Tregnaghi M.W., Madhi S.A., Razmpour A., Palladino G., et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J 2009 May, 28(5):365-371.
69. Tam J.S., Capeding M.R., Lum L.C., Chotpitayasunondh T., Jiang Z., Huang L.M., et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007 Jul, 26(7):619-628.
70. Lum L.C., Borja-Tabora C.F., Breiman R.F., Vesikari T., Sablan B.P., Chay O.M., et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine 2010 Feb 10, 28(6):1566-1574.
71. Jackson M.L. Confounding by season in ecologic studies of seasonal exposures and outcomes: examples from estimates of mortality due to influenza. Ann Epidemiol 2009 Oct, 19(10):681-691.
72. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008 Nov, 122(5):911-919.
73. Szilagyi P.G., Fairbrother G., Griffin M.R., Hornung R.W., Donauer S., Morrow A., et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 2008 Oct, 162(10):943-951.
74. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009 Jan 15, 199(2):159-167.
75. Heinonen S., Silvennoinen H., Lehtinen P., Vainionpaa R., Ziegler T., Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011 Jan, 11(1):23-29.
76. Kelly H.A., Grant K.A., Fielding J.E., Carville K.S., Looker C.O., Tran T., et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011 Aug 26, 29(37):6419-6426.
77. Vesikari T., Knuf M., Wutzler P., Karvonen A., Kieninger-Baum D., Schmitt H.J., et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011 Oct 13, 365(15):1406-1416.
78. Podda A., Del G.G. MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile. Expert Rev Vaccines 2003 Apr, 2(2):197-203.
79. Jefferson T., Rivetti A., Di P.C., Demicheli V., Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2012, 8. CD004879.
80. Liang X.F., Li L., Liu D.W., Li K.L., Wu W.D., Zhu B.P., et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011 Feb 17, 364(7):638-647.
81. Block S.L., Ruiz-Palacios G.M., Guerrero M.L., Beygo J., Sales V., Holmes S.J. Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. Pediatr Infect Dis J 2012 Jul, 31(7):e92-e98.
82. Vesikari T., Karvonen A., Tilman S., Borkowski A., Montomoli E., Banzhoff A., et al. Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence. Pediatrics 2010 Oct, 126(4):e762-e770.
83. De W.P., Deceuninck G., Toth E., Boulianne N., Brunet D., Boucher R.M., et al. Risk of Guillain-Barre syndrome following H1N1 influenza vaccination in Quebec. J Am Med Assoc 2012 Jul 11, 308(2):175-181.
84. Dieleman J., Romio S., Johansen K., Weibel D., Bonhoeffer J., Sturkenboom M. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011, 343:d3908.
85. Yin J.K., Khandaker G., Rashid H., Heron L., Ridda I., Booy R. Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respi Virus 2011 Sep, 5(5):299-305.
86. European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy. Euro Surveill 2010 Sep 23, 15(38).
87. Miller E., Andrews N., Stellitano L., Stowe J., Winstone A.M., Shneerson J., et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013, 346:f794.
88. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavainen T., Sundman J., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012, 7(3):e33536.
89. Partinen M., Saarenpaa-Heikkila O., Ilveskoski I., Hublin C., Linna M., Olsen P., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012, 7(3):e33723.
90. Izurieta H.S., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. J Am Med Assoc 2005 Dec 7, 294(21):2720-2725.
91. Rowhani-Rahbar A., Klein N.P., Lewis N., Fireman B., Ray P., Rasgon B., et al. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol 2012 May 1, 175(9):878-885.
92. Ambrose C.S., Dubovsky F., Yi T., Belshe R.B., Ashkenazi S. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing. Eur J Clin Microbiol Infect Dis 2012 Oct, 31(10):2549-2557.
93. Toback S.L., Ambrose C.S., Eaton A., Hansen J., Aukes L., Lewis N., et al. A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age. Vaccine 2013 April 3, 31(14):1812-1818.
94. Vasu N., Ghaffari G., Craig E.T., Craig T.J. Adverse events associated with intranasal influenza vaccine in the United States. Ther Adv Respir Dis 2008 Aug, 2(4):193-198.
95. Bodewes R., Kreijtz J.H., Rimmelzwaan G.F. Yearly influenza vaccinations: a double-edged sword?. Lancet Infect Dis 2009 Dec, 9(12):784-788.
96. Bodewes R., Kreijtz J.H., Baas C., Geelhoed-Mieras M.M., de M.G., van A.G., et al. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One 2009, 4(5):e5538.
97. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006 Dec, 80(23):11756-11766.
98. Berthoud T.K., Hamill M., Lillie P.J., Hwenda L., Collins K.A., Ewer K.J., et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 2011 Jan 1, 52(1):1-7.
99. Hoft D.F., Babusis E., Worku S., Spencer C.T., Lottenbach K., Truscott S.M., et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011 Sep 15, 204(6):845-853.
100. Chen G.L., Lau Y.F., Lamirande E.W., McCall A.W., Subbarao K. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc Natl Acad Sci U S A 2011 Jan 18, 108(3):1140-1145.
101. Heikkinen T., Peltola V. Influenza vaccination of children. Lancet Infect Dis 2009 Dec, 9(12):720-721.
102. Lewis E.N., Griffin M.R., Szilagyi P.G., Zhu Y., Edwards K.M., Poehling K.A. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 2007 Sep, 120(3):467-472.
103. Loeb M., Russell M.L., Moss L., Fonseca K., Fox J., Earn D.J., et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. J Am Med Assoc 2010 Mar 10, 303(10):943-950.
104. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001 Mar 22, 344(12):889-896.
105. Salo H., Kilpi T., Sintonen H., Linna M., Peltola V., Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006 Jun 5, 24(23):4934-4941.
106. Nichol K.L. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 2011 Oct 6, 29(43):7554-7558.
107. Newall A.T., Jit M., Beutels P. Economic evaluations of childhood influenza vaccination: a critical review. Pharmacoeconomics 2012 Aug 1, 30(8):647-660.
108. Pitman R.J., Nagy L.D., Sculpher M.J. Cost-effectiveness of childhood influenza vaccination in England and Wales: results from a dynamic transmission model. Vaccine 2013 Jan 30, 31(6):927-942.
109. Tengs T.O., Adams M.E., Pliskin J.S., Safran D.G., Siegel J.E., Weinstein M.C., et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995 Jun, 15(3):369-390.
110. Carcione D., Giele C., Dowse G.K., Mak D.B., Goggin L., Kwan K., et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 2010 Sep, 16(9):1388-1395.
111. Ciftci E., Tuygun N., Ozdemir H., Tezer H., Sensoy G., Devrim I., et al. Clinical and epidemiological features of Turkish children with 2009 pandemic influenza A (H1N1) infection: experience from multiple tertiary paediatric centres in Turkey. Scand J Infect Dis 2011 Dec, 43(11-12):923-929.
112. Okada T., Morozumi M., Matsubara K., Komiyama O., Ubukata K., Takahashi T., et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother 2011 Apr, 17(2):238-245.